Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

Plaudits, Progress and Partnerships – One important lesson in the push for equality!

Read the full article…

Posted in Workplace Diversity | Tagged , , , , , , , , , , , | Leave a comment

Clarus Ventures Strengthens Investment Team with 3 Hires

Clarus Ventures, a life sciences investment firm, has appointed Kiran Reddy and Robert DeBenedetto to Venture Partner, and Lazar Dimitrov to Associate. Based in the firm’s Cambridge, Mass. office, Reddy will focus on both new company formation and risk-sharing partnerships with pharmaceutical companies. DeBenedetto and Dimitrov will be based in Clarus’ South San Francisco, Calif. office.

Read the full article…

Posted in Executive Appointments | Tagged , , , , , , , , , , , , | Leave a comment

Third Rock Ventures Recruits Industry Heavyweight Michael Bonney

Boston based venture capital powerhouse Third Rock Ventures, have announced the appointment of Michael W. Bonney as partner. Mr. Bonney was previously the CEO of Cubist Pharmaceuticals until its acquisition by Merck & Co. Mr. Bonney brings to Third Rock extensive operational, commercial, and senior management expertise in the biopharmaceutical industry. Prior to serving as the CEO of Cubist from June 2003 until December 2014, Mike served as president and chief operating officer of the company, joining in 2002. From 1995 to 2001, he held various positions of increasing responsibility at Biogen, including vice president, sales and marketing. Prior to joining Biogen, he held positions in sales, marketing, and strategic planning at Zeneca Pharmaceuticals, concluding his 11-year career there as national business director. He currently also serves as a board director of two significant biotech companies, Celgene and Alnylam.Watch Full Movie Online Streaming Online and Download

Read the full article…

Posted in Executive Appointments | Tagged , , , , , , , , , , | Leave a comment

Scott Morrison Nets Two Board Appointments

Scott Morrison, a retired Ernst & Young Partner, was appointed to the board of directors at Audentes Therapeutics and Global Blood Therapeutics.Watch Full Movie Online Streaming Online and Download

Read the full article…

Posted in Board Director Appointments | Tagged , , , , , , , , , , | Leave a comment

$40m for rare focused Rhythm

Rhythm announced today the completion of a $40 million Series A financing for its subsidiary, Rhythm Metabolic, Inc., which is developing setmelanotide (RM-493), a novel peptide MC4 agonist for the treatment of obesity caused by genetic deficiencies in the MC4 pathway. In this round, new investors OrbiMed, Deerfield Management, Wellington Management Company, and an undisclosed public healthcare investment fund joined existing investors MPM Capital, New Enterprise Associates, Third Rock Ventures, Pfizer Ventures, and Ipsen. Associated with the financing, Jonathan Silverstein, JD, Partner and Co-Head of Global Private Equity at OrbiMed, joined the Rhythm Metabolic Board of Directors.

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , | Leave a comment

Editas adds CFO and $120m in Series B round

Editas Medicine, a leading genome editing company, today announced that it has raised $120 million in a highly oversubscribed Series B private financing. The financing assembles a broad syndicate of leading public and private investors who underpin many of the most innovative biopharmaceutical and technology companies.

Read the full article…

Posted in Executive Appointments, M&A Finance and Funding | Tagged , , , , , , , , , , , , , , | Leave a comment

Executive and Board Director Appointments in Oncology and Rare Diseases

Third Rock Ventures portfolio company, Voyager Therapeutics, a gene therapy player in the field of CNS based out of Cambridge, Mass. have appointed Michael Higgins to the Board of Directors. Mr. Higgins is an experienced biotechnology executive and is currently an entrepreneur-in-residence at Polaris Partners. Previously, he served as chief operating officer and chief financial officer at Ironwood Pharmaceuticals, Inc. from 2003 through 2014. In 2014, Mr. Higgins was named the Boston Business Journal’s CFO of the Year. Mr. Higgins worked at Genzyme Corporation, with which Voyager Therapeutics now has a partnership, from 1997 through 2003 in a variety of leadership roles, including vice president of corporate finance and vice president of business development. While at Genzyme, he was involved with multiple business units, including Cell Therapy, Gene Therapy and Orphan Diseases.

Read the full article…

Posted in Executive Appointments | Tagged , , , , , , , , , , , , , , , , | Leave a comment

What does it take to reach and succeed at the ‘C’ and Board level?

Liftstream has been collaborating with two organisations to put together a key leadership meeting on gender diversity in biotechnology. The event is based on our published research and we have worked with our network of executives to bring about an incredible panel of industry leaders.

Read the full article…

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Third Rock Ventures shows promise with early stage investment strategy

Posted in Uncategorized | Tagged , , , , , , , , , , | Leave a comment

Executive Recruitment Roundup – July

Authored by Liftstream

Read the full article…

Posted in Executive Appointments, Recruitment Market | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Contact Us

   Head Office
Liftstream Ltd.
111 Buckingham Palace Road,
   Tel: ​+44 (0)20 3180 5880

Register your CV

Apply for sector specific vacancies or request a confidential discussion

Registered in England No: 5009233
VAT: 843679292

Follow Us